Over the last two decades, there have been tremendous advances in the non-invasive
diagnosis and risk stratification of chronic liver diseases (CLDs). Non-invasive approaches …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …

Importance Chronic hepatitis C (CHC) and its complications are associated with high rates
of morbidity and mortality. However, large-scale data analysis of the long-term liver and …

Traditionally, the progression from compensated to decompensated cirrhosis has been
regarded as a point of no return in the natural history of the disease. However, this point of …

Background & Aims The prognostic impact of acute decompensation (AD), ie the
development of complications that require hospitalization, has recently been assessed …

Objectives To quantify mortality rates for patients successfully treated for hepatitis C in the
era of interferon-free, direct acting antivirals and compare these rates with those of the …

The indolent and aggressive behaviors of HCC might have a role in clinical trial (CT) results;
however, the indolent HCC is less analyzed compared to others cancer. Indolent profile …

Etiological cure prevents further decompensation and mortali... : Hepatology Etiological cure
prevents further decompensation and mortality in patients with cirrhosis with ascites as the single …

Simple Summary In the present study we investigated the ability of different non-invasive
scoring systems (ie, Forns index, APRI, FIB-4, ALBI, and aMAP) to predict hepatocellular …

It is estimated that 58 million people suffer from chronic hepatitis C virus (HCV) infection
worldwide, which significantly contributes to chronic liver disease and liverrelated mortality …